These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23352426)

  • 21. Multivessel percutaneous coronary intervention without contrast agents.
    Vidi VD; Barseghian A; Garratt KN
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):E222-E226. PubMed ID: 26708315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.
    Aksoy O; Tuzcu EM; Ellis SG; Whitlow PL; Cam A; Batizy L; Agarwal S; Franco I; Bajzer C; Simpfendorfer C; Raymond R; Nair R; Cho L; Shishehbor MH; Lincoff AM; Kapadia SR
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E1-8. PubMed ID: 22508442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention.
    Nozue T; Michishita I; Iwaki T; Mizuguchi I; Miura M
    J Cardiol; 2009 Oct; 54(2):214-20. PubMed ID: 19782258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of automated right ventricular segmentation using dual-bolus contrast media injection with 256-slice coronary CT angiography.
    Kondo M; Nagao M; Yonezawa M; Yamazaki Y; Shirasaka T; Nakamura Y; Honda H
    Acad Radiol; 2014 May; 21(5):648-53. PubMed ID: 24703478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing iodinated contrast volume by manipulating injection pressure during coronary angiography.
    Kaye DM; Stub D; Mak V; Doan T; Duffy SJ
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):741-5. PubMed ID: 24323791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel automated injection system for angiography.
    Goldstein JA; Kern M; Wilson R
    J Interv Cardiol; 2001 Apr; 14(2):147-52. PubMed ID: 12053296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.
    Senoo T; Motohiro M; Kamihata H; Yamamoto S; Isono T; Manabe K; Sakuma T; Yoshida S; Sutani Y; Iwasaka T
    Am J Cardiol; 2010 Mar; 105(5):624-8. PubMed ID: 20185007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of coronary angiography using 4F catheters: 4F manual versus "Acisted" power injection technique.
    Chahoud G; Khoukaz S; El-Shafei A; Azrak E; Bitar S; Kern MJ
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):221-4. PubMed ID: 11387608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of amount of contrast utilized in patients undergoing percutaneous coronary procedures.
    Pradhan J; Niraj A; Afonso L
    Coron Artery Dis; 2007 Jun; 18(4):275-82. PubMed ID: 17496491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
    Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
    J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.
    Gibson CM; Buros J; Ciaglo LN; Southard MC; Takao S; Harrigan C; Filopei J; Lew M; Marble SJ; Murphy SA; Cohen MG;
    Am J Cardiol; 2007 Jul; 100(1):13-7. PubMed ID: 17599433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery injection technique: a quantitative in vivo investigation using modern catheters.
    Dodge JT; Nykiel M; Altmann J; Hobkirk K; Brennan M; Gibson CM
    Cathet Cardiovasc Diagn; 1998 May; 44(1):34-9. PubMed ID: 9600520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L; Pu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computed tomographic angiography-verified plaque characteristics and slow-flow phenomenon during percutaneous coronary intervention.
    Kodama T; Kondo T; Oida A; Fujimoto S; Narula J
    JACC Cardiovasc Interv; 2012 Jun; 5(6):636-43. PubMed ID: 22721658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography.
    Joshi SB; Mendoza DD; Steinberg DH; Goldstein MA; Lopez CF; Raizon A; Weissman G; Satler LF; Pichard AD; Weigold WG
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1404-11. PubMed ID: 20083076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary intervention with 4-French catheters.
    Takeshita S; Tanaka S; Saito S
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):735-9. PubMed ID: 20049960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.